Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity

    January 2025 in “ JID Innovations
    Nicole Vecin, Nathan C. Balukoff, Marita Yaghi, Tammy Gonzalez, Andrew P. Sawaya, Nataša Štrbo, Marjana Tomic‐Canic, Hadar Lev‐Tov, Hye Lim Keum
    TLDR Hidradenitis suppurativa tunnels worsen the disease and often need surgery because current treatments are not very effective.
    Hidradenitis suppurativa (HS) tunnels are advanced structures in the disease that significantly impair quality of life and resist current medical therapies, often requiring surgical intervention. These tunnels are characterized by epithelial-lined structures within the dermis and contribute to a cycle of inflammation and disease progression, involving activated keratinocytes, microbial dysbiosis, and IL-17–producing T cells. The study highlights the need for further research into the mechanisms of tunnel formation and persistence to develop targeted therapies, as current treatments, including biological medications, show limited efficacy. The document emphasizes the importance of understanding the cellular and microbial interactions in HS tunnels to improve patient outcomes and reduce the healthcare burden.
    Discuss this study in the Community →

    Research cited in this study

    15 / 15 results